170522 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation Serum albumin, e.g. HSA
PARTICLE FOR IMMUNOAGGLUTINATION ASSAY AND TEST REAGENT FOR IN VITRO DIAGNOSIS
#2METHOD OF BREAST CANCER BIOMARKER DETECTION USING A BIOSENSOR BASED ON A FIBER-OPTIC BALL RESONATOR
#3ANALYZER FOR AUTOMATICALLY DETECTING AND QUANTIFYING GLUTARALDEHYDE IN BIOCIDE PRODUCTS
#4DNA APTAMERS THAT BIND TO ALGINATE GELS
#5CA-IX TARGETING FLUORESCENT PROBES
#6METHODS OF DETERMINING A HEALTH STATUS OF A DOG BASED ON ONE OR MORE BIOMARKERS, AND METHODS OF TREATING A MORTALITY RISK IDENTIFIED BY THE HEALTH STATUS
#7KIT FOR QUANTITATIVE ANALYSIS OF GLYCATED ALBUMIN, METHOD FOR QUANTITATIVE ANALYSIS OF GLYCATED ALBUMIN, AND APPARATUS FOR PERFORMING THE SAME
#8KIT FOR QUANTITATIVE ANALYSIS OF C-REACTIVE PROTEIN, METHOD FOR QUANTITATIVE ANALYSIS OF C-REACTIVE PROTEIN, AND APPARATUS FOR PERFORMING THE SAME
#9MICROFLUIDIC URINE ALBUMIN/CREATININE CHIP (uACR-CHIP) FOR CHRONIC KIDNEY DISEASE EVALUATION
#10SYNTHESIS OF SELF-ASSEMBLING ARTIFICIAL PROTEINS UTILIZING A HOST-GUEST SYSTEM AND USES THEREOF
#11METHOD FOR PREDICTING PROGNOSTIC INDICATIONS OF PANCREATIC CANCER PATIENTS
#12IN VITRO METHODS
#13ENHANCEMENT COMPOSITIONS AND USES THEREOF
#14RAPID DETECTION OF AT LEAST ONE TOXIN USING A MICROFLUIDIC DEVICE
#15DEVICE AND METHOD FOR LOCALISING OR IDENTIFYING MALIGNANCIES
#16Luminescent probe and its preparation method and application
#17LATERAL FLOW IMMUNOASSAY DEVICE FOR ALBUMIN DETECTION
#18ASSAY METHOD OF ANTIBODY
#19SYNTHETIC CONTROLS FOR IMMUNOHISTOCHEMISTRY
#20METHOD FOR ESTIMATING THE PROBABILITY OF MALADAPTIVE GLOMERULAR IMPAIRMENT IN KIDNEY DISEASES
#21METHODS AND KITS FOR DETECTING CANNABINOIDS
#22MULTIPLEXED NANO-BIOSENSOR SYSTEM FOR EARLY DETECTION OF DIABETES
#23METHOD AND DEVICE FOR DETECTING BIOMOLECULE
#24MICROFLUIDIC PLATFORM FOR DETECTION OF LIVER INJURY
#25SAMPLE ANALYSIS METHOD, SAMPLE PRODUCTION METHOD, DILUENT FOR DILUTING ALBUMIN- AND y-GLOBULIN-CONTAINING SAMPLE, AND SAMPLE ANALYSIS KIT
#26URINARY TRACT INFECTION DIAGNOSTIC
#27Serum Albumin-Binding Fibronectin Type III Domains
#28Method for Correction for Sample Volume
#29IMPROVED METHOD AND TEST SYSTEM FOR IN-VITRO DETERMINATION OF DRUG ANTIBODIES IN BLOOD
#30METHOD OF SCREENING FOR A CHRONIC KIDNEY DISEASE OR GLOMERULOPATHY METHOD OF MONITORING A RESPONSE TO TREATMENT OF A CHRONIC KIDNEY DISEASE OR GLOMERULOPATHY IN A SUBJECT AND A METHOD OF TREATMENT OF A CHRONIC KIDNEY DISEASE OR GLOMERULOPATHY
#31METHOD FOR MEASURING TEAR CONSTITUENTS IN A TEAR SAMPLE
#32METHODS, SYSTEMS, AND COMPOSITIONS FOR STUDYING SOLVENT ACCESSIBILITY AND THREE-DIMENSIONAL STRUCTURE OF BIOLOGICAL MOLECULES
#33IN VITRO DIAGNOSTIC METHOD FOR ALZHEIMER'S DISEASE BASED ON THE ALBUMIN REDOX LEVEL IN THE CEREBROSPINAL FLUID
#34Test piece for albumin measurement
#35Methods for determining amount of functional albumin
#36ASSAY METHODS FOR THE DETECTION OF HUMAN SERUM ALBUMIN, VITAMIN D, C-REACTIVE PROTEIN, AND ANTI-TRANSGLUTAMINASE AUTOANTIBODY
#37METHODS AND KITS FOR DETECTING LIVER DYSFUNCTION IN A SUBJECT
#38Method for Predicting Prognosis of Ischemic Disease
#39OPTICAL BIOSENSOR COMPRISING DISPOSABLE DIAGNOSTIC MEMBRANE AND PERMANENT PHOTONIC SENSING DEVICE
#40Serum albumin-binding fibronectin type III domains
#41METHODS AND DEVICES FOR DETECTING DIABETIC NEPHROPATHY AND ASSOCIATED DISORDERS
#42METHODS FOR QUANTITATING PROTEIN BIOMARKERS
#43Synthetic controls for immunohistochemistry
#44BIOMARKERS FOR PREDICTING DEGREE OF WEIGHT LOSS
#45URINARY TRACT INFECTION DIAGNOSTIC
#46Methods, systems, and compositions for studying solvent accessibility and three-dimensional structure of biological molecules
#47VITRO DIAGNOSTIC METHOD FOR ALZHEIMER'S DISEASE BASED ON THE ALBUMIN REDOX LEVEL IN THE CEREBROSPINAL FLUID
#48Method for measuring tear constituents in a tear sample
#49Methods for determining the relative binding capacity of albumin
#50IMMUNOREGULATORY STRUCTURES FROM NORMALLY OCCURING PROTEINS
#51Method for Measuring Tear Constituents in a Tear Sample
#52BIOMARKERS FOR PREDICTING DEGREE OF WEIGHT LOSS
#53Method for measuring tear constituents in a tear sample
#54BIOMARKERS OF METHYLGLYOXAL AND RELATED METHODS THEREOF
#55Humanized affinity matured anti-FcRn antibodies
#56PHARMACOKINETIC ANIMAL MODEL
#57Antagonists to IL-6 to Raise Albumin and/or Lower CRP
#58TEST FOR MONITORING RENAL DISEASE
#59Device and method for detecting creatinine and albumin to creatinine ratio
#60Blood analysis method and blood test kit
#61Compositions and methods for diagnosing, monitoring, and treating an autoimmune disease
#62BIOMARKERS FOR PREDICTING DEGREE OF WEIGHT LOSS
#63IMMUNOREGULATORY STRUCTURES FROM NORMALLY OCCURING PROTEINS
#64Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders
#65Methods, systems, and compositions for studying solvent accessibility and three-dimensional structure of biological molecules
#66Antagonists of IL-6 to raise albumin and/or lower CRP
#67Methods to Diagnose and Treat Multiple Sclerosis via Detection of Altered Protein Components of Serum
#68METHODS AND DEVICES FOR DETERMINING A DISEASE STATE
#69Electrochemical biosensor and a method of sensing albumin and its complexes
#70COMPOSITIONS FOR DETECTING CANCER CELLS ON A CELLULAR SURFACE
#71Glycated protein assay
#72In vitro process for the quantification of carboxymethyl and carboxyethyl level of albumin in a sample
#73Mass spectrometric quantitation
#74Molecular Imaging Probes
#75FUNCTIONAL LIGANDS TO TARGET MOLECULES AND METHODS
#76Customized quality controls for analytical assays
#77DIAGNOSIS OF CHRONIC KIDNEY DISEASE BY QUANTITATIVE ANALYSIS OF POST-TRANSLATIONAL MODIFICATIONS OF PLASMA PROTEINS
#78Protein fluorescent nanoparticles and methods of synthesis thereof
#79METHOD FOR DETECTING CADMIUM AND KIT FOR DETECTING CADMIUM USING FLUORESCENCE INTENSITY ACCORDING TO FORMATION OF CADMIUM NANOCLUSTER
#80Prediction of acute kidney injury from a post-surgical metabolic blood panel
#81Fructose amino acid oxidase, preparation method and enzyme-containing kit for detecting glycated albumin
#82DIABETES PANEL
#83Methods and devices for detection and measurement of analytes
#84CROSSLINKED POLYMER STATIONARY PHASE FOR CHROMATOGRAPHY
#85Squaraine based fluorescent probe and a process for the preparation thereof
#86Antagonists to IL-6 to raise albumin and/or lower CRP
#87STRESS AND INFLAMMATION BIOMARKER URINE PANEL FOR DAIRY COWS AND BEEF CATTLE
#88COMPOSITIONS FOR OVARIAN CANCER ASSESSMENT HAVING IMPROVED SPECIFICTY
#89Assays and methods of treatment relating to vitamin D insufficiency
#90Specific fluorescent probe based on albumin pseudo-esterase hydrolysis reaction and use thereof
#91Kits for Fecal Neopterin Concentration Measurement as an Indicator of Disease Activity in Inflammatory Bowel Disease
#92ALBUMIN VARIANTS BINDING TO FCRN
#93Methods of treating malignant tumors
#94PHARMACOKINETIC ANIMAL MODEL
#95Methods and devices for determining a disease state
#96Labeling composition for cancer lesion
#97Megastokes amino-triazolyl-BODIPY compounds and applications to live neuron staining and human serum albumin FA1 drug site probing
#98Biomarkers for the identification of liver damage
#99Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders
#100Peptide Analogues of PA-IL and Their Utility for Glycan and Glycoconjugate Analysis and Purification
#101Human hepatoma cell line HLCZ01 and uses thereof
#102METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#103Methods and kits for detection of active malignancy
#104Rapid test for urine albumin and urine creatinine
#105Diagnosis, prognosis, and treatment of kidney disease
#106Methods of detecting ovarian cancer
#107DIABETES PANEL
#108Method of improving patient survivability and quality of life by anti-IL-6 antibody administration
#109Sentinel lymph node marker capable of multi-mode imaging
#110Assays for anti-drug antibodies in the presence of abundant endogenous protein counterpart of the drug
#111FECAL NEOPTERIN CONCENTRATION MEASUREMENT AS AN INDICATOR OF DISEASE ACTIVITY IN INFLAMMATORY BOWEL DISEASE
#112Serum markers associated with early and other stages of breast cancer
#113Methods of reducing CRP and/or increasing serum albumin in patients in need using IL-6 antibodies of defined epitopic specificity
#114Immunoassay method
#115Methods of immunoregulation by albumin neo-structures
#116MICROBUBBLES FOR AFFINITY SEPARATION
#117Microbubbles for affinity separation
#118Methods and Devices for Detecting Kidney Transplant Rejection
#119Method of assaying complex and kit to be used therefor
#120Carbamylated proteins and risk of cardiovascular disease
#121Devices for Detecting Renal Disorders
#122Methods and Devices for Detecting Kidney Damage
#123Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders
#124Computer Methods and Devices for Detecting Kidney Damage
#125Methods and devices for detecting obstructive uropathy and associated disorders
#126Methods and Devices for Detecting Glomerulonephritis and Associated Disorders
#127METHOD FOR DIRECT DETECTION OF ISCHEMIA-MODIFIED ALBUMIN USING A PARTNER FOR BINDING TO AN ALDEHYDE DERIVATIVE RESULTING FROM THE PEROXIDATION OF LIPIDS IN BOUND FORM
#128Assays
#129Mass Spectrometric Quantitation
#130Rapid Test for Glycated Albumin
#131MICROCHIP FOR PROTEIN FIXATION
#132Assay Device and Method
#133Fluorescent water-soluable conjugated polyene compounds that exhibit aggregation induced emission and methods of making and using same
#134Antagonists of IL-6 to raise albumin and/or lower CRP
#135Biomarkers of ionizing radiation
#136Biomarkers for assessing liver function
#137Immunological latex turbidimetry method and reagent therefor
#138Microbubbles for affinity separation
#139Method of detecting protein losing enteropathy in animals
#140Aflatoxin-albumin adduct measurement and the uses thereof
#141Method and system for determining whether additional laboratory tests will yield values beyond a threshold level
#142Albumin binding sites for evaluating drug interactions and methods of evaluating or designing drugs based on their albumin binding properties
#143Anti-feline albumin antibodies
#144Rapid test for glycated albumin in saliva
#145Rapid test for glycated albumin
#146Electrochemical detection of ischemia
#147Apparatuses and methods for reducing albumin in samples
#148Apparatuses and methods for reducing albumin in samples